Xiaotan Jieyu Prescription Alleviates Breast Precancerous Lesions through PI3K/Akt Signaling Pathway

Table 1

Visible breast tumors of rats in each group.

Group	The number of breast tumors of rats
	4th week	8th week	10th week	12th week
BLA (n = 5)	0/5	0/5	0/5	0/5
DLD (n = 12)	0/12	3/12 (25.0%)	5/12 (41.7%)	7/12 (58.3%)
DMD (n = 12)	0/12	7/12 (58.3%)	11/12 (91.7%)	12/12 (100%)
DHD (n = 12)	0/12	9/12 (75.0%)	11/12 (91.7%)	12/12 (100%)

Data were expressed as means ± standard deviation. compared with the BLA group.